Hi Peter, I agree with you abt the teva's optimistic tone. But from the fda's point of view, what's the hurry? There is a generic and they will be closely watching for any immunogenicity issues for at least some time like 6months to an yr. I feel they won't take addn risk by approving teva's now.
do u follow IRWD? Any thoughts on their results today?